News
Stockhead on MSN29m
Recce to expand Phase II trial for diabetic foot infectionsRecce Pharmaceuticals receives Human Research Ethics Committee approval to expand its phase II clinical trial following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback